It's a complex SEC set of regs, partly, over my pay grade. My experts say the new shares must all be seasoned for a year after it goes back to SEC reporting. There is no way this stays on OTC.
Also there may be say 10 bag holders holding 10% each of the new AS shares, that can not be sold with out SEC filings/and pre-arranged Liquidation plans. If they even plan to sell any after a year.
The kind of people that funded this company are use to holding for a decade or more...Keystone Nano was Private for 15 years.
My best Guess is they get more money up front with Licensing deals early on, but if they wanted to raise a lot of cash for the long haul they shove the stock price way past $100/share and then raise really cheap money at $100/share for any kind of Phase III drug trials.
Or they license it out to folks like NVS-Novartis who have a 300 Billion dollar market cap and world wide distribution infrastructure for Rx drugs....
They could end up with dozens of licenses and deals!!! Each worth billions over time.
News 
Market Data 
Discover 
AI
